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Abstract
The replacement histone variant H2AX senses DNA double-strand breaks (DSBs) and recruits
characteristic sets of proteins at its phosphorylated (γ-H2AX) foci for concurrent DNA repair. We
reasoned that the H2AX interaction network, or interactome formed in the tumor-associated DNA
DSB environment such as in hepatocellular carcinoma (HCC) cells, where pre-neoplastic lesions
frequently occur, is indicative of HCC pathogenic status. By using an in vivo dual-tagging
quantitative proteomic method, we identified 102 H2AX-specific interacting partners in HCC cells
that stably expressed FLAG-tagged H2AX at close to the endogenous level. Using bioinformatics
tools for data-dependent network analysis, we further found binary relationships among these
interactors in defined pathway modules, implicating H2AX in a multi-functional role of
coordinating a variety of biological pathways involved in DNA damage recognition and DNA
repair, apoptosis, nucleic acid metabolism, Ca2+-binding signaling, cell cycle, etc. Furthermore
our observations suggest that these pathways interconnect through key pathway components or
H2AX interactors. The physiological accuracy of our quantitative proteomic approach in
determining H2AX-specific interactors was evaluated by both co-immunoprecipitation/
immunoblotting and confocal co-localization experiments performed on HCC cells. Due to their
involvement in diverse functions, the H2AX interactors involved in different pathway modules,
such as Poly(ADP-ribose) polymerase1, 14-3-3ζ, coflin1, and peflin1, were examined for their
relative H2AX binding affinities in paired hepatocytes and HCC cells. Treatment with the DSB-
inducing agent bleomycin enhanced binding of these proteins to H2AX, suggesting an active role
of H2AX in coordinating the functional pathways of each protein in DNA damage recognition and
repair.
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Introduction
DNA double-strand breaks (DSBs) induced by various stresses1–5 represent a common
genomic damage/lesion that may lead to genomic instability and ultimately, to cancer
development2, 6. The replacement histone variant H2AX7 8 plays a central role in both
cellular responses to DNA damage and in repairing damaged DNA2, 3. In the early cellular
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response to DNA DSBs, H2AX is phosphorylated at serine 139, probably by ataxia
telangiectasia mutated (ATM), triggering various signal transduction cascades for DNA
damage recognition and DNA repair9, 10. The phosphorylated form of H2AX or γ-H2AX
can recruit particular sets of proteins such as MRE11, RAD50, and NBS1 (MRN) in a
complex with Brca1, 53BP1, and NFBD1/DNA damage checkpoint 1(MDC1) to form γ-
H2AX foci at DNA DSB sites11–13. For example, MDC1 recognizes γ-H2AX through its
BRCT domain, and facilitates recruitment of additional MRN and ATM proteins that
subsequently leads to the phosphorylation of additional H2AX and MDC1 molecules14, 15.
The MRN complex can interact directly with MDC1, then MDC1 binds ATM through its
FHA domain and NBS1 through its Ser-Asp-Thr repeat14, 15. Other evidence suggests that
the ubiquitin-interacting-motif-containing protein RAP80 binds K63-linked ubiquitin chains
of ubiquitinated proteins and, therefore, is able to recognize ubiquitinated H2A/H2AX,
resulting in formation of a larger BRCA1/BARD1/CCDC98/RAP80 protein complex
targeted to DNA damage foci14, 16, 17. In addition to these H2AX interacting proteins,
many pivotal DNA repair-related proteins such as 53BP118 have also been found to interact
with H2AX through different recruiting mechanisms.
H2AX and its interacting proteins play synergistic roles in tumourigenesis19, 20. H2AX
knockout mice were found with increased genomic instability and a higher risk of
developing cancers11, 21. Mutations or deletions in the H2AX gene are frequently found
associated with various human cancers including acute myeloid leukemia, acute lymphoid
leukemia, head and neck squamous carcinoma, etc8, 22–26. In tumor cells from clinical
specimens and cell culture, emerging evidences also showed increased levels of DNA DSBs
and mutations in H2AX-interacting partner genes27, 28. Defects in DNA damage response
pathways, such as the MRN complex or the kinases ATM and RAD3-related (ATR), are
associated with cancer predisposition syndromes in humans, and disruption of DNA repair
systems in mouse models leads to an increased risk of cancer29, 30. H2AX and its
interacting proteins such as ATM, Chk2, p53 were found activated in bladder cancer31.
Immunohistochemistry studies have shown DNA damage signal activation in precancerous
bladder lesions, which is lost on progression, suggesting that the damage signaling acts as a
brake to further tumorigenesis32. In addition, expression of RAD51, one of the critical
H2AX interactors, is higher in breast cancer than in normal breast tissue33. We therefore
reasoned that different compositions of H2AX complexes may be specifically correlated to
different human cancers, wherein the H2AX-associated pathways for DNA damage
recognition and repair could be dys-regulated leading to un-repairable DNA DSBs.
Emerging mass spectrometry(MS)-based proteomic approaches with improved sensitivity,
signal specificity, and throughput have been extended to efficiently and systematically
analyze protein complexes and decipher protein interaction networks34–36. Metabolic
labeling strategies such as SILAC/AACT26 have improved the signal specificity in
distinguishing genuine protein-protein interactions in protein complexes37, 38. In our
previous studies of ionizing radiation-induced dynamic changes in the H2AX interactome
using a dual-tagging quantitative proteomic approach38, we found several novel binding
partners of H2AX in human embryonic kidney (HEK) 293T cells under defined conditions,
and demonstrated that the H2AX protein complex underwent dynamic changes upon
induction of DNA damage and during DNA repair. Further analysis revealed a critical role
for Ca2+/calmodulin in ionizing radiation-induced cell cycle arrest in HEK cells. Despite
growing evidence of correlations between an abnormal H2AX interactome, and
carcinogenesis, little is known how a characteristic H2AX interactome is structured in
cancer cells and how it is dysregulated in respond to DNA DSBs and repair. Hepatocellular
carcinoma (HCC) is the third leading cause of cancer-related death worldwide39. This high
mortality is mainly due to unknown mechanisms of HCC pathogenesis and lack of precise
HCC-characteristic markers for early diagnosis and therapeutic intervention39, 40. One of
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the conspicuous features of HCC development is the frequent occurrence of chromosomal
abnormalities39. Microarray analyses revealed that expression of many DNA repair-related
proteins was up-regulated in HCC cells40. Also HCC tissues accumulate higher endogenous
levels of γ-H2AX foci41. Some evidence suggests that the regulatory level of γ-H2AX may
be tissue-specific42, 43. Also, variable expression patterns of an H2AX partner, NBS1, in
testis, thymus, spleen telencephalon, diencephalon, liver, lung, kidney, and gut are observed
in mice44. Organ-specific factors may have an impact on PARP-1, another H2AX
interactor, to protect against genotoxic damage in mice45. We therefore hypothesize that
H2AX may recruit particular sets of protein interactors in HCC cells whereby H2AX
coordinates complex cellular signals indicative of the pathological environment in HCC.
We describe here the use of DNA nuclease digestion of nuclei and a dual tagging (both
epitope and SILAC tag) quantitative proteomics strategy37, 38, to profile proteins
interacting with H2AX in HCC cells. Using bioinformatics tools, we performed data-
dependent network analysis to first validate protein interactions with H2AX and second to
sort out their binary interactions. As an immediate outcome, multiple pathway modules were
mapped and their interconnected links were established. The proteomic dataset and the
selected components of particular pathway modules were further validated by co-
immunoprecipitation/immunoblotting. The endogenous interactions between H2AX and
selected interacting partners representing the pathways involved in DNA damage
recognition and repair were localized by confocal scanning. Using bleomycin (BLM), the
most used agent to induce DNA DSBs46, 47 we then examined the possible role of certain
H2AX interactors in DNA damage recognition and repair in HCC cells. We also compared
the H2AX binding affinities of the proteins in paired hepatocytes and HCC cells48. All of
these results provide insight into an HCC-characteristic H2AX interactome indicative of the
pathological status of hepatocellular carcinoma.
Experimental Procedures
Materials
Deuterium-labeled leucine (5, 5, 5-d3) was purchased from Cambridge Isotope (Andover,
MA). Trypsin was purchased from Promega (Madison, WI). Hoechst 33342 was purchased
from Sigma (St. Louis, MO). All components of cell culture medium were purchased from
Invitrogen Corporation (Carlsbad, CA) except for puromycin, which was obtained from
Calbiochem (San Diego, CA) and fetal bovine serum (FBS), which was obtained from PAA
Laboratories GmbH (Linz, Austria). Chemicals for IP, SDS-PAGE gel electrophoresis,
visualization, peptide extraction, and sample preparation of LTQ-Orbitrap were purchased
from Sigma (St. Louis, MO). All the chemicals were sequence- or HPLC -grade unless
specifically mentioned.
The antibodies used in immunoblotting and immunofluorescence studies were purchased
from different companies, such as H2AX(ab11175, ab22551), γ-H2AX(ab2893), β-actin
(ab16039) and GAPDH(ab8245) from Abcam; PARP-1 (sc-1561), 14-3-3ζ(sc-1019) from
Santa Cruz Biotechnology; CALR(10292-A-AP), NONO(11058-1-AP), CFL1(10960-1-
AP), PEF1(10151-1-AP) and NCL(10556-1-AP) from Protein Tech Group; anti-
FLAG(F1860) from Sigma; FITC-conjugated goat anti-rabbit secondary antibody (75230)
and TRITC-conjugated goat anti-mouse secondary antibody (61551) from Jackson
ImmunoResearch Laboratories, Inc.
The cell line QSG-7701 and QGY-7703 were purchased from Shanghai Institute of
Biochemistry and Cell Biology (SIBCB, Shanghai, China). QSG-7701 and QGY-7703 were
originally established in QiDong, the highest morbidity area of HCC in China. The
hepatoma cell line QGY-7703 was derived from primary carcinoma of a 35 years old
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female, and its normal liver counterpart QSG-7701 was from peripheral non-tumor tissue of
the same surgery specimen.
Plasmids, Stable Cell Lines, and Dual-tagging (FLAG tag and isotope tag) Quantitative
Proteomics Approach
Expression plasmids for H2AX were described previously37, 38. The construct containing
the FLAG tag alone or FLAG-H2AX was transfected into human HCC cells (QGY-7703)
using the Lipofectemin™ 2000 reagent according to the manufacturer, and the cells were
selected in RPMI-1640 supplemented with 10% dialyzed FBS, 100U/ml penicillin and
streptomycin, and 1.0 μg/ml puromycin. Whereas the cells containing the tag alone (control
cells) were cultured in regular unlabeled RPMI-1640 medium, the cells containing FLAG-
tagged H2AX (FLAG-H2AX cells) were maintained in RPMI-1640 containing Leu-d3 to
isotopically label the proteome. A detailed procedure has been described previously37, 38.
Histone Isolation
Histone extraction was performed as described previously15. Briefly, cells were lysed in
0.5% NP40, 100 mM NaCl, 50 mM Tris, 1 mM EDTA. After centrifugation, histones were
extracted by resuspending pellets with 0.2 N HCl. The HCl extracts were centrifuged, and
the supernatants (histone extracts) were then neutralized with 1 N NaOH and blotted with
anti-H2AX or anti-γ-H2AX antibodies.
Protein Extraction and Purification of H2AX Protein Interaction Partners
Protein extraction and purification were performed as described previously with minor
modifications38. Briefly, approximately 8×108 FLAG-H2AX cells and control cells were
harvested, then equal numbers of each cell line were mixed. The mixed cells were lysed.
After nuclear isolation and nuclease digestion, the nuclear extract was incubated with 200 μl
of M2 anti-FLAG beads at 4°C for 6 h with 20% glycerol and 150 mM NaCl. The beads
were then washed four times with TBS. The bound protein complexes were then solubilized
in sample buffer, and separated by 12% SDS-PAGE. After staining with Coomassie Brilliant
Blue, visible bands were cut for in-gel digestion. The extracted peptides were lyophilized for
LC-MS/MS.
LC-MS/MS Analysis
LC-MS/MS experiments were performed on a LTQ-Orbitrap hybrid mass spectrometer
(Thermo Finnigan, Bremen, Germany) equipped with a Finnigan Dynamic nano-spray
source. Sample was injected via an SIL-20 AC auto-sampler (Shimadzu Corporation,
Tokyo, Japan) and loaded onto a CAPTRAP column (0.5×2 mm, Michrom Bioresources
Inc., Auburn, CA) for 5 min at a flow rate of 60μL/min. The peptide mixtures was
subsequently separated by a PICOFRIT C18 reverse-phase column (0.075×100 mm, New
Objective Inc., Woburn, MA) at a flow rate of 300nL/min with a 110 min-gradient. Buffer A
was 5% ACN, 0.1% formic acid; buffer B was 95% ACN, 0.1% formic acid. Samples were
loaded in solvent A, and peptides were eluted by 5% solvent B for 5 min followed by a
linear gradient to 45% solvent B in the next 90 min, ramping to 95% solvent B in 4 min and
dropping to 90% solvent B for 4 min before re-equilibrating the system to 10% solvent B for
7 min. The LTQ-Orbitrap mass spectrometry was operated in the data-dependent mode
using the TOP3 strategy. In brief, a scan cycle was initiated with a full scan of mass range
(m/z 400–2000) in the Orbitrap under the target mass resolution of 60,000, which was
followed by MS/MS scans in the linear ion trap on the 3 most abundant precursor ions.
Single charged ions were excluded from MS/MS analysis.
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Database Search and Protein Identification
Applying the TurboSequest V.27 (rev.12) search engine, we searched all MS/MS spectra
against human reference database (IPI 3.27). Searches were performed with the following
parameters: Trypsin enzyme specificity with allowing one missed cleavage; a precursor
tolerance of 10 ppm and fragment tolerance of 1 Da; dynamic modifications of d3-labeled
Leu (+3.018). Positive identifications were made according to a rigorous statistical model as
Peptide Prophet and reverse database search49, 50. In detail, for SEQUEST engine, all
peptides must have a ΔCn of at least 0.1 and cross correlation values (XCorr) were assigned
with at least 1.90 (+1 charge), 3.23 (+2 charge) and 3.66(+3 charge) by reverse database
search evaluation (p=0.05). Additionally, the computed probability through Peptide Prophet
of trans-proteomic pipeline (TPP) tools must be over 0.99 for each peptide51. Protein
assignments were made only if the protein had at least two different peptides passing the
above criteria. In order to eliminate redundant protein identifications that matched the same
set of peptides (protein group), a parsimonious interpretation method was applied to result in
a minimized dataset. Reproducibility was assessed primarily according to the method of
Blagoev et al52.
Data-dependent bioinformatics for network analysis
Functional classification of identified proteins was accomplished by using Entrez Gene
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db_gene) and DAVID (http:/
www.david.abcc.ncifcrf.gov). Proteins with multiple functions were assigned to those that
are best known. Pathway module analysis of the functional clusters was performed by
STRING (http://www.string.embl.de), a database of known and predicted protein-protein
interactions.
Immunoblotting Analysis
Cells (7×107 cells/assay) were harvested for nuclei isolation/digestion, immunoprecipitation,
and immunoblotting. The procedures for nuclei isolation/digestion and immunoprecipitation
were essentially the same as described as above, except that buffer volumes in each step
were reduced ~10-fold. The immunoprecipitated proteins were eluted by boiling the beads
and separated on SDS-PAGE. The proteins were then transferred to a PVDF membrane
(Bio-Rad) and incubated with the specified primary antibody followed by incubation with a
secondary antibody conjugated to horseradish peroxidase. The ECL substrate was then
added and the blot was developed.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 15 min, washed in PBS, and blocked in 10%
normal goat serum with 0.1% Triton X-100 for 1 h at room temperature. The fixed cells
were incubated with anti-γ-H2AX (phosphorylated form) antibody overnight at 4°C,
followed by incubation with TRITC-conjugated goat anti-mouse secondary antibody for 1 h
at room temperature. Cells were washed in PBS. Slides were incubated sequentially with
other primary antibodies overnight at 4°C and FITC-conjugated goat anti-rabbit secondary
antibody for 1 h at room temperature. After washing, cells were counterstained with Hoechst
33342. Then slides were mounted in glycerol/PBS solution. All primary antibodies were
used at dilutions of 1:200 to 1:800. The secondary antibodies included anti-rabbit FITC and
anti- mouse TRITC and were used at dilutions of 1:200. Immunofluorescence images were
captured using a laser scanning confocal microscope (Zeiss, LSM 510 system or Leica TCS-
SP15, Germany).
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HCC cells were seeded in 10 cm dishes. When they were 90–95% confluent, the cells were
treated with BLM. γ- H2AX was detected with different concentrations of BLM and
different times of treatment. The cells treated with optimized conditions (40mU/ml BLM
and harvested after 3 hours) were selected for immunoblotting analysis.
Binding Comparative Assay
A stable cell line of hepatocytes (QSG-7701) was produced as described above. Hepatocytes
and HCC cells were harvested for nuclei isolation digestion, immunoprecipitation, and
immunoblotting analysis.
Results and Discussion
In vivo expression and subcellular location of epitope-tagged H2AX in hepatocellular
carcinoma (HCC) cells
To identify H2AX-interacting proteins from HCC cells, we generated a HCC cell line stably
expressing human FLAG tagged-H2AX at close to the natural level, using the retroviral
gene transfer method which we reported previously37, 38. In the stable cell line, we first
examined the subcellular location of the tagged-H2AX by using a sequential histone
extraction method15. Each fraction of the extraction was examined by immunoblotting
against H2AX antibody. As shown in Fig.1A, FLAG-tagged H2AX was detected only in the
nuclear/histone components, suggesting that the FLAG-tagged H2AX was incorporated into
chromatin similar to our previous observations38. Also expression of FLAG-tagged H2AX
was found at a level similar to that of endogenous H2AX (Fig.1B, left). The phosphorylated
form of FLAG-tagged-H2AX, γ-H2AX, was also detected at an abundance slightly higher
than that of its endogenous counterpart (Fig. 1B, middle). Similarly, anti-FLAG was used to
detect ectopically expressed ɣ-H2AX and H2AX (Fig. 1B, right).
Given the fact that H2AX senses DNA DSBs through site-specific phosphorylation53, we
expected to observe a portion of γ-H2AX in HCC cells where many un-repairable DSBs
may exist. In fact, after several passages the expression level of the epitope-tagged H2AX
became even lower than the untagged endogenous form (Table S1). Furthermore, the stable
HCC cells expressing the FLAG-tagged H2AX showed a growth rate and morphology
similar to the parental cells, indicating that expression of the FLAG-tagged H2AX had no
effect on the phenotype of the stable cells. Collectively the above results suggested that the
FLAG-tagged H2AX, like its endogenous counterpart, was correctly packaged into
nucleosomes and functioned in a physiologically relevant condition in chromatin.
Identification of H2AX-interacting components formed in HCC cells using a dual-tagging
(FLAG tag and isotope tag) quantitative proteomics approach
The strategy for affinity purification and identification of H2AX-interacting proteins is, with
a few modifications, similar to that described previously38. Briefly, the HCC cell line stably
expressing FLAG-H2AX was maintained in a “heavy” medium containing leucine-d3,
whereas the control cells were cultured in the regular (or “light”) medium. Equal amounts of
cells from each culture were combined. After nuclei isolation/digestion, extraction and IP,
the immunoprecipitated proteins were eluted and separated on SDS-PAGE (Fig 2B). All gel
bands were digested with trypsin followed by LC-MS/MS for peptide separation and protein
identification. In our MS analysis, all of the leucine-containing peptides appeared as pairs in
the MS spectrum with one set of peaks from the stable isotope-labeled cells and the other set
of peaks from the unlabeled cells. The intensity ratios of the paired peaks reflect the binding
profiles of the protein to the bait protein H2AX. For those H2AX-interacting proteins, the
heavy isotope signals should be more intense than their lighter counterparts, suggesting
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enrichment of these proteins around the H2AX bait. Because background binding occurs
randomly in both IP purifications, the ratio of the “heavy” (H) versus “light” (L) peptide
intensities (H/L) for bait-nonspecific binding proteins should be 1:1.
The procedure for protein identification and quantitative measurements was carried out
similarly to that described previously37, 54. As shown in Figure 2A, for the distribution of
H/L for all proteins identified, the proteins previously known to interact with H2AX such as
Calreticulin (CALR) were found with H/L ratios > 1.34. Empirically, we selected this value
as the threshold for distinguishing specific interactors from non-specific contaminants as all
proteins with H/L less than 1.34 were considered as non-specific background. We then
searched the available information about the known functional category and the possible
H2AX-interacting nature of our identified interactors by using public interaction databases
such as oPHID, IntAct, BioGRID, and HPRD. As summarized in Table 1, among 102
proteins distinguished as the H2AX interactors 15 of them are known H2AX interacting
partners.
Functional categories of the identified H2AX-interacting proteins in HCC cells
By searching Entrez Gene (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db_gene) and
DAVID (http://www.david.abcc.ncifcrf.gov), we found that most of the H2AX interacting
proteins identified by our proteomic method were clustered in diverse functional categories.
As shown in Table 1 and Fig. 3, these functional categories include DNA damage
recognition/repair, cell cycle, apoptosis, cellular localization, response to stimulus/oxidative
stress/hypoxia, alcohol metabolic processes, DNA and RNA metabolism, cellular
macromolecule metabolism, redox homeostasis, Ca2+-binding signaling, etc.
The distribution of the identified H2AX interactors in these functional categories is given in
Figure 3. Using a similar dual-tagging strategy, those proteins including Calmodulin, CALR,
PARP-1, histone H4, etc, were also found to interact with H2AX in the human embryonic
kidney (HEK) 293T cells38. The identification of these H2AX-interacting partners in both
HEK and hepacellular carcinoma cell types suggested there are core components in the
H2AX complex regardless of the difference in cell types. Because of their functional
relevance to Ca2+ signaling-related cell cycle, apoptosis, and DNA damage recognition and
repair, etc, the core role of H2AX-interacting complexes in coordinating these biological
processes was clearly suggested. In addition we have identified many more H2AX-
intercating partners in HCC cells in which some may be HCC-specific and others may be
due to the higher sensitivity of LTQ-orbitrap compared to the ABI Qstar/Qtof used
previously. The largest portion of the H2AX interactome in HCC cells was represented by
proteins involved in macromolecule metabolism including both nucleic acid and protein
metabolism, and carbohydrate catabolism. This observation suggested that H2AX may
recruit these proteins for readily activating multiple functional pathways such as energy
generation, protein synthesis, RNA splicing and transport, translational control, gene
regulation, etc24, 55–57. Interestingly, in our dataset (Table 1) many H2AX interactors such
as CFL1, HSP90B1 and ANXA5 possess anti-apoptotic functions58 59. A possible
explanation is that H2AX may recruit these proteins in a complex to protect the damaged or
un-repairable cells from apoptosis in hepacellular carcinoma. In addition, one group of
interactors has known functions in alcohol metabolic processes and oxidative stress. Alcohol
has long been recognized as a major risk factor for HCC development60, 61 62, and
acetaldehyde, the main metabolite of alcohol, was reported to cause hepatocellular injury
and is an important factor in causing increased oxidative stress, which damages DNA62.
Examples of our identified H2AX interactors in this category are enolase 1 (ENO1),
Fructose-bisphosphate aldolase A (ALDOA), and Isoform 1 of GDP-fucose protein O-
fucosyltransferase 1 precursor (POFUT1), which may take part in alcohol metabolism in
liver physiology and pathology.
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Data-dependent network analysis of the H2AX-interacting proteins identified in HCC cells
reveals that H2AX coordinates cross-talk among diverse pathway modules
To elucidate how H2AX coordinates multiple functional pathways in the tumor environment
and the possible functional role of the H2AX interactome in HCC, we explored the inter-
connected relationship among the H2AX interactors and further identified each of different
pathway modules. By using the STRING mapping tool, the sub-networks operating each
pathway module could be mapped and specifically defined with the associated function. As
shown in Figure 4, H2AX was found to be the critical network node in a variety of the
identified pathway modules associated with apoptosis and cell cycle control (Fig. 4A), DNA
repair (Fig. 4B), alcohol metabolism (Fig. 4C), carbohydrate catabolism and cellular
macromolecule metabolism (Fig. 4D), stress response (Fig. 4E), and RNA processing (Fig.
4F). Further, given their previously known multi-functional nature, certain H2AX
interactors, for instance, YWHAB and YWHAE (also named as 14-3-3 isomers), were found
in multiple pathway modules related to apoptosis, cell cycle, and DNA repair (Fig. 4A&4B).
EIF4A1 and RPS10 were shown in all pathway modules associating with carbohydrate
catabolism, macromolecule metabolism, and DNA repair (Fig. 4B–4D). TOR1A, LMNA,
and HYOU1 were shared by both pathway modules related to stress response and DNA
repair (Fig.4B&4E). Notably, we have detected some vital proteins such as PARP-1,
HSP90AA1, etc, previously known as components of multiple signaling pathways related to
DNA damage recognition and repair. Although our network analysis suggested that p53, a
key tumor suppressor protein,63, 64 could be a critical node in a number of pathway
modules (Fig.4), it was not identified in our mass spectrometry experiments. In response to
DNA damage, p53 accumulates in differentiated cells, and activates particular target genes
that initiate cell cycle arrest or apoptosis63. The p53-regulated tumor suppressor pathway is
frequently inactivated in cancer65. A possible explanation of our results was that most of the
pathway modules identified in our networks analysis could be more p53-independent than
p53-dependent in the HCC cells, or both mechanisms may co-exist. PARP-1 is multi-
functional in many pathways including those related to DNA damage/repair3, 66, 67.
HSP90AA1 is a molecular chaperone involved in both formation and maintenance of proper
conformation of proteins and promoting cell survival in response to stress26, 68.
This data-dependent network analysis not only provided further support for the accuracy of
our determination of the H2AX-interacting partners but also the binary relationships among
these interactors, as most of them could be identified in the corresponding pathway
module(s). More importantly, H2AX was shown to promote cross-talk in these
interconnected pathway modules. Clearly, these pathway modules coordinated by H2AX
may sense intrinsic stress such as un-repaired DNA DSBs in HCC cells, transduce the signal
in recognizing DNA damage, and selectively activate biological processes such as apoptosis,
cell cycle arrest, or DNA repair.
Validation of the HCC-specific H2AX interactome dataset using immunoblotting
We used co-immunoprecipitation (co-IP) and concurrent immunoblotting to evaluate the
physiologically relevant accuracy of our proteomics dataset of the HCC cell H2AX-
interacting complex. In our selected pool of H2AX interactors, proteins such as PARP-1,
CALR, non-pou domain-containing octamer-binding protein (NONO), 14-3-3ζ, CFL1, and
PEF1 were known to be involved in individual or multiple pathway modules associated with
DNA damage recognition/repair, apoptosis, and cell cycle control respectively and could
represent each of individual pathway modules. The known H2AX interactors such as
PARP-1, CALR and NONO were found to interact with H2AX in HCC cells while other
proteins previously unknown to interact with H2AX such as 14-3-3ζ, CFL1 and PEF1 were
also identified as H2AX-inetracting partners in HCC cells.
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Poly(ADP-ribose) polymerases, or PARPs, which showed 1.8 fold enrichment in the H2AX
complex (Table 1) are a class of cell signaling enzymes functioning in poly(ADP-
ribosylation) of DNA-binding proteins69. PARP-1 is best known to be involved in the
cellular response to DNA damage69, 70 in addition to its associations with various pathways
including DNA replication, DNA repair, recombination, gene transcription, cell proliferation
and death71. PARP-1 participates in DNA DSB repair through either nonhomologous end-
joining (NHEJ) or homologous recombination (HR)3, and is believed to be a `sensor' in
detecting DNA damage and initiating DNA repair72. Earlier reports suggested the increased
level of PARP-1 in cancer cells might promote their survival72, 73. PARP-1 inhibitors have
been used in cancer chemotherapy in combination with anti-tumor drugs having DNA-
binding properties74, 75. A previous study also indicated that PARP-1 expression was
significantly increased in human HCC compared to its surrounding liver tissue76, 77. Also
PARP-1 was found to contribute to HBV-related hepatocarcinogenesis78. Our study here
has provided direct evidence suggesting that the role of PARP-1 in HCC might be due to its
interaction with H2AX in the HCC cells.
14-3-3ζ is one of the isoforms in the 14-3-3 family of regulators of diverse cellular
responses in both physiological and pathological conditions79. 14-3-3ζ is an important
regulatory protein in intracellular signaling pathways and is known to interact with more
than 100 cellular proteins, including many oncogene and proto-oncogene products80.
14-3-3ζ blocks apoptosis by inhibiting activation of p38 mitogen-activated protein kinase
(MAPK) and could be an anti-apoptotic factor in cells81. 14-3-3ζ was also reported to
interact with β-catenin, and to enhance or to inhibit β-catenin-dependent transcription. It
also facilitates activation of β-catenin through Akt, and is possibly involved in stem cell
development82. Furthermore, 14-3-3ζ is up-regulated in a number of cancer cell types83,
84. Evidence indicates that 14-3-3ζ plays a role in keratin filament organization in
hepatocytes, and regulates mitotic progression66, 85. In our analysis (Table 1), 14-3-3ζ was
identified as an intrinsic interactor of H2AX in HCC cells.
Cofilin-1 (CFL1) is a small ubiquitous protein that binds both monomeric and filamentous
actin, and, through its ability to sever actin filaments, is an essential regulator of actin
dynamics at the plasma membrane during cell migration86. Aberrant regulation of cell
migration drives the progression of many diseases, including cancer invasion and
metastasis87. CFL1 may be involved in cancer cell migration, invasion, and metastasis88–
90. In the highly metastatic human HCC cells such as MHCC97-H91, a decreased level of
CFL1 was found. Furthermore, some studies suggest CFL1 may relate to radio-sensitivity by
altering DNA repair capacity87 since key components for repair of DNA DSBs, including
RAD51, RAD52, and Ku70/Ku80, were down-regulated in CFL1 over-expressing cells
following ionizing radiation87. Interestingly, CFL1 was identified with 1.9 fold increase in
its binding to H2AX in HCC cells.
One of the penta-EF-hand (PEF) proteins, PEF1, is a Ca2+-binding protein92 functioning in
Ca2+-mediated signaling irrespective of cell type93. PEF1 dimerizes with apoptosis-linked
gene 2 (ALG-2) and modulates the function of ALG-2 in Ca2+ signaling92. Our previous
study in HEK 293 cells showed that the H2AX interactome plays a important role in
ionizing radiation-induced cell cycle arrest through Ca2+ signaling pathways38.
Similar to the design of validation experiments38, the immunoblotting assay using
corresponding protein antibodies was performed on the same amount of the
immunoprecipitates derived from FLAG-alone HCC cells (parental) and FLAG-H2AX
stable HCC cells, respectively. H2AX-specific interactions for the selected proteins found in
HCC cells are shown in Fig. 5, and are consistent with our quantitative proteomic dataset.
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In situ localization of endogenous H2AX-specific interactions using confocal laser
scanning
With the positive control of the known H2AX-PARP1 interaction, by using confocal
scanning, we further examined the endogenous interactions of H2AX with its newly
identified partners such as 14-3-3ζ, CFL1, and PEF1 in `resting' HCC cells. As shown in
Figure 6, endogenous phosphorylated (γ)-H2AX stained with red fluorescence was
observed in the nucleus. Stained with green fluorescence, either 14-3-3ζ, CFL1, PEF1, or
PARP-1 were also found in the nucleus (in blue). Although in a small population, γ-H2AX
was found to co-localize with either PARP-1, or 14-3-3ζ, or CFL1 or PEF1 in the nucleus of
HCC cells as seen by the bright merged spots (arrowhead in Fig 6). As a result, for the first
time, the interactions of H2AX with 14-3-3ζ, CFL1, PEF1 and PARP-1 were observed at
the endogenous level in HCC cells based on both proteomic and immunoassay/confocal
results.
The correspondence between methods indicates the accuracy and reliability of our dual-
tagging quantitative method for profiling bait-specific interacting partners. The results also
suggest that these H2AX interactors function in DNA damage recognition/repair, apoptosis,
and cell cycle control through their interactions with H2AX or mediated by H2AX.
H2AX recruits particular interacting proteins in response to bleomycin (BLM)-induced DNA
damage in HCC cells
To understand the functional role of the HCC-specific H2AX-interacting complexes in
diverse functions of DNA damage recognition and repair, apoptosis, and cell cycle control in
response to DNA DSBs, we next studied the changes in H2AX binding by the interactors
representing each functional category. Bleomycin (BLM) was used to trigger the response to
instant DNA DSBs47, 94. Because H2AX can sense the extent of BLM-induced DNA
DSBs, we first examined both dose- and time course-dependent BLM-induced
phosphorylation at H2AX to determine the condition of maximum effect of BLM. As shown
in Fig.7A, the abundance of phosphorylated H2AX or γ-H2AX increased along with BLM
treatment at a defined dose of 40 mg/ml for an extended period of time until a maximum
level was reached after approximately 3 hours. Under this condition, the H2AX-interacting
complex was first pulled down through immunoprecipitation using anti-FLAG beads. Using
the same approach, the immunoprecipitate was obtained from non-stimulated HCC cells
stably expressing FLAG-tagged H2AX. Using the antibodies against each of the H2AX
interactors such as PARP-1, 14-3-3ζ, CFL1 and PEF1, immunoblotting experiments were
performed on equal amounts of the immunoprecipitates derived from BLM-stimulated
versus non-stimulated HCC cells. In these co-immunoprecipitation and immunoblotting
experiments, the amount of FLAG tag detected was used as the control. As shown in Figure
7B, the abundance of PARP-1, CFL1, PEF1, or 14-3-3 ζ in the H2AX-interacting complex
increased proportionally along with the BLM-induced increase of γ-H2AX (Table S2),
suggesting that these proteins were recruited through interaction with H2AX to the complex
that participates in the processes of recognizing BLM-induced DNA DSBs or DNA damage.
In addition to its known role in DNA repair, with still largely unknown mechanism γ-H2AX
may participate in regulation of a variety of biological processes such as cell cycle,
chromatin remodeling, etc9, 95. For example, two distinct γ-H2AX foci were found in non-
irradiated or `resting' cells96. One predominant population of small foci did not co-localize
with DSB repairing proteins, while another small population of large foci co-localized with
many repair proteins and resembled IR-induced foci96. It has also been shown that H2AX
can be phosphorylated independently of DNA DSBs, and that this phosphorylation could be
involved in regulating the cell cycle independently of sensing DNA damage or promoting
repair96, 97. Also H2AX may function to promote chromatin remodeling98.
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Our results for BLM-inducible γ-H2AX interactions in HCC cells revealed that upon BLM-
induced DSBs, γ-H2AX could interact with those proteins representing diverse functional
categories of DNA DSB recognition such as PARP-1, the cytoskeleton such as CFL1, Ca2+
signaling such as PEF1, etc. The BLM-induced composition of γ-H2AX foci provides an
insight into the molecular mechanisms underlying how γ-H2AX turnover keeps cell cycle
checkpoints active until any DNA damage is repaired.
Comparative analysis of the H2AX interacting partners in paired hepatocytesversus HCC
cells
On the basis of the profiling dataset of the H2AX interacting partners, we selected certain
core components identified in the complex to compare their relative binding affinities to
H2AX in the paired hepatocytes and HCC cells. These comparative studies were performed
on two cell lines derived from healthy liver and carcinoma tissue of the same donor with the
same genetic background, i.e., QSG-7701 for normal and QGY-7703 for HCC
respectively48. We also generated the QSG-7701 or QGY-7703 cell lines expressing only
FLAG (parental) and FLAG-tagged H2AX respectively. Co-immunoprecipitation and
immunoblotting experiments were performed on the pair of QSG-7701 and QGY-7703 both
stably expressing FLAG-tagged H2AX in contrast to their corresponding parental cells. As
shown in Figure 8, with respect to the abundance of FLAG tag in the immunoprecipitates as
the loading control, the expression of γ-H2AX did not show a significant difference
between these cell lines. Measured by Fujifilm Las-3000 Luminescent image analyzer, the
H2AX interacting partners such as PARP-1, 14-3-3ζ, and CFL1 displayed enhanced binding
to H2AX in QGY-7703 HCC cells compared to that in normal QSG-7701 hepatocytes
(Table S3). PARP-1 was among those interactors showing a relatively stronger enhancement
for its binding to H2AX in HCC cells.
Defects in the DNA damage recognition and repair pathways contribute to genome
instability and promote tumorigenesis3. It has been documented that the processes of DNA
damage response and repair remain active during tumourigenesis31, 99, probably due to
stress-inducing DNA damage in the rapidly dividing pre-neoplastic lesions31, 99 100, 101.
Improper DNA damage recognition and DNA repair could contribute to the survival and
apoptotic resistance of cancer cells. Clearly, our observations support these notions at the
molecular level with a systems view, suggesting that not only the phosphorylated H2AX but
its interactors with characteristic binding strength are responsive to intrinsic DSBs/DNA
damage in tumor cells.
Conclusions
Using a dual-tagging quantitative proteomic approach we have dissected a cell type-specific
H2AX interactome. The HCC profile of the H2AX-interacting partners identified by our
approach first suggested a multi-functional role of H2AX in mediating many biological
pathways/processes such as DNA damage recognition, DNA repair, apoptosis, cell cycle,
protein metabolism, cellular localization, etc. Network analysis further indicated the cross-
talk among functional clusters. The physiologically relevant accuracy of these interactions
was validated by immunoassys and the cellular localization of these interactions at the
endogenous level was determined by confocal scanning microscopy. The stimulation of
HCC by a DNA DSB-inducing agent, BLM, allowed us to determine the role of those
interactions in the cellular response to DNA damage. The differential strengths of H2AX in
recruiting its interactors were studied in paired hepatocyte and HCC cells, suggesting that
H2AX mediates the differential cellular response in carcinogenesis through interacting with
different strengths with its partners. Our results of dissecting HCC-characteristic H2AX
interactome have provided insight into possible markers indicative of the pathological status
of HCC.
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Figure 1. Expression of FLAG-tagged H2AX in stable QGY-7703 cells
(A). FLAG-tagged H2AX was detected only in the nuclear fraction, not in the cytoplasmic
fraction. Equal amounts of protein (40μg) extracted from cytoplasm and nuclear fraction of
cells stably expressing FLAG-tagged H2AX (FLAG-H2AX cells) were loaded onto a 12%
SDS-polyacrylamide gel for Western blotting (WB) analysis. GAPDH and endogenous
H2AX were detected and used as the control markers of the cytoplasmic and nuclear
fractions, respectively. (B). FLAG-tagged H2AX and its phosphorylated form were
expressed at a level comparable to that of its endogenous counterpart. Equal amounts of
protein (15μg) extracted from the parental 7703 cells and the FLAG-H2AX cells were
loaded onto a 15% SDS-polyacrylamide gel for Western blotting (WB) analysis using either
anti-H2AX or anti-phospho-H2AX or anti-FLAG antibody. The bands appearing close to 15
or 25 kDa corresponded to the endogenous or FLAG-tagged H2AX, respectively.
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Figure 2. AACT/SILAC-based MS analysis of H2AX complexes
(A) The distribution of H/L ratio of the identified proteins in the H2AX complex formed in
HCC cells. The threshold for distinguishing specific interactors from non-specific
contaminants was an H/L of 1.34. The sign of diamond, circle and square indicate those
proteins with H/L over 1.34, suggesting specificity in associating with H2AX, while a
triangle represents a protein with H/L less than 1.34 or a non-specific protein in the
complex. The green square represents the bait protein. The red circles indicate proteins
known previously to interact with H2AX in other types of cells. The blue diamonds suggest
newly identified H2AX-interacting partners. (B) SDS-PAGE analysis of FLAG-
immunoprecipitates as visualized by Coomassie Brilliant staining. The band of FLAG-
tagged H2AX is indicated by arrow.
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Figure 3. The distribution of HCC cell H2AX interacting proteins in different functional
categories
The identified proteins were analyzed by bioinformatics tools using Entrez Gene and KEGG
databases. A total of 102 proteins identified as H2AX-interacting partners were found to be
associated with fourteen functional categories or biological processes. Proteins with multiple
functions were assigned to the best known function.
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Figure 4. The H2AX-associating pathway modules found in the HCC-specific H2AX interactome
The regulatory/signaling pathway modules of identified proteins were analyzed by DAVID
and STRING 8.1 (http://www.string.embl.de/). (A) apoptosis and cell cycle, (B) DNA
repair, (C) alcohol metabolism, (D) carbohydrate catabolism and cellular macromolecule
metabolism, (E) stress response, (F) RNA processing and protein synthesis.
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Figure 5. Immunochemical analyses of selected proteins identified as H2AX-interacting partners
in HCC cells
The immunoprecipitated proteins from FLAG-QGY-7703 cells and FLAG-H2AX-
QGY-7703 cells were analyzed by immunoblotting (IB). Anti-FLAG antibody was used to
detect H2AX with nuleolin (NCL) as a loading control. Lane 1: the QGY-7703 cells
expressing FLAG alone; lane 2: the QGY-7703 cells stably expressing FLAG-H2AX.
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Figure 6. Confocal laser scanning analysis of co-localized endogenous interactions between γ-
H2AX and either 14-3-3ζ, or PEF1, or PARP-1 or CFL1 respectively using
The parental QGY7703 cells were stained with TRITC for γ-H2AX (red), and with FITC
for either PARP-1, or 14-3-3ζ, or PEF1 or CFL1 respectively (green). The nucleus was
stained with Hoechst 33342 (blue). With a scale bar of 10 μm the merged images are
indicated by white foci. All foci are indicated by white arrows. The confocal images of co-
localized (A). γ-H2AX and PARP-1, (B). γ-H2AX and 14-3-3 ζ, (C). γ-H2AX and PEF1,
and (D). γ-H2AX and CFL1.
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Figure 7. Immunoblotting analysis of bleomycin (BLM)-induced changes in the H2AX binding to
its interacting partners
(A) Time course-dependent BLM-induced phosphorylation of H2AX in HCC cells, and (B)
Immunoprecipitates isolated from either untreated or BLM-stimulated cells (40 U/ml for 3
hours), respectively, were analyzed by immunoblotting (IB). The FLAG tag was detected
and used as the loading control. Lane 1: from the untreated FLAG-H2AX-QGY-7703 cells;
lane 2: from the BLM-stimulated FLAG-H2AX-QGY-7703 cells.
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Figure 8. Comparative analysis of the H2AX binding with selected protein partners in paired
hepatocytes (QSG-7701)versusHCC (QGY-7703) cells
Using the antibodies as indicated in the Figure, immunoprecipitates were obtained from
QSG-7701 cells expressing FLAG alone, QSG-7701 cells expressing FLAG-H2AX, the
QGY-7703 cells expressing FLAG alone and QGY-7703 cells expressing FLAG-H2AX
respectively. In immunoblotting (IB) analysis, the FLAG tag was detected and used as the
loading control. Lane1: from the FLAG-QSG-7701 cells; lane2: from the FLAG-H2AX-
QSG-7701 cells; lane3: from the FLAG-QGY-7703 cells; lane4: from the FLAG-H2AX-
QGY-7703 cells.
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